Feasibility of vitamin D supplementation interventions to mitigate HIV pre-exposure prophylaxis-related bone mineral density loss: a cross-sectional survey

References

• RiddellJAmicoKRMayerKHHIV Preexposure prophylaxis: a reviewJAMA2018319121261126829584848
   PubMed Web of Science ®Google Scholar
• MulliganKGliddenDVAndersonPLEffects of emtricitabine/tenofovir on bone mineral density in HIV-negative persons in a randomized, double-blind, placebo-controlled trialClin Infect Dis201561457258025908682
   PubMed Web of Science ®Google Scholar
• KasondeMNiskaRWRoseCBone mineral density changes among HIV-uninfected young adults in a randomised trial of pre-exposure prophylaxis with tenofoviremtricitabine or placebo in BotswanaPLoS One201493e9011124625530
   PubMed Web of Science ®Google Scholar
• LiuAYVittinghoffESellmeyerDEBone mineral density in HIV-negative men participating in a tenofovir pre-exposure prophylaxis randomized clinical trial in San FranciscoPLoS One201168e2368821897852
   PubMed Web of Science ®Google Scholar
• SaxPEWohlDYinMTTenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trialsLancet201538599872606261525890673
   PubMed Web of Science ®Google Scholar
• MillsAArribasJRAndrade-VillanuevaJSwitching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority studyLancet Infect Dis2016161435226538525
   PubMed Web of Science ®Google Scholar
• ArribasJRThompsonMSaxPEBrief report: randomized, double-blind comparison of tenofovir alafenamide (TAF) vs tenofovir disoproxil fumarate (TDF), each coformulated with elvitegravir, cobicistat, and emtricitabine (E/C/F) for initial HIV-1 treatment: week 144 resultsJ Acquir Immune Defic Syndr201775221121828282300
   PubMed Web of Science ®Google Scholar
• SaxPEZolopaABrarITenofovir alafenamide vs. tenofovir disoproxil fumarate in single tablet regimens for initial HIV-1 therapy: a randomized phase 2 studyJ Acquir Immune Defic Syndr2014671525824872136
   PubMedGoogle Scholar
• Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide (F/TAF) Fixed-Dose Combination Once Daily for Pre-Exposure Pro-phylaxis in Men and Transgender Women Who Have Sex With Men and Are At Risk of HIV-1 Infection (DISCOVER) [Internet]US Library of Medicine2016 [cited 2018-08-16]. Available from: https://www.nlm.nih.gov/bsd/uniform_requirements.html#electronic
   Google Scholar
• Health CanadaPMS-emtricitabine-tenofovir2017 Available from: https://pdf.hres.ca/dpd_pm/00040337.PDFAccessed October 11, 2018
   Google Scholar
• Health CanadaAPO-tenofovir2018 Available from: http://www.health.gov.nl.ca/health/_scripts/class_search_nl.asp?din=02451980&GReturn=GenericName&subtitle1=Generic%20or%20Brand%20Name%20:%20%20%20&subtitle2=&tempformulary=Accessed October 11, 2018
   Google Scholar
• Health CanadaMylan-emtricitabine/tenofovir disoproxil2017 Available from: http://www.gilead.ca/application/files/1715/3185/3013/Truvada_English_PM_e133222-GS-017.pdfAccessed October 11, 2018
   Google Scholar
• Health CanadaTEVA-emtricitabine/tenofovir2017 Available from: https://pdf.hres.ca/dpd_pm/00040336.PDFAccessed October 11, 2018
   Google Scholar
• OvertonETChanESBrownTTVitamin D and calcium attenuate bone loss with antiretroviral therapy initiation: a randomized trialAnn Intern Med20151621281582426075752
   PubMed Web of Science ®Google Scholar
• HavensPLStephensenCBvan LoanMDDecline in bone mass with tenofovir disoproxil fumarate/emtricitabine is associated with hormonal changes in the absence of renal impairment when used by HIV-uninfected adolescent boys and young men for HIV preexposure prophylaxisClin Infect Dis201764331732528013265
   PubMed Web of Science ®Google Scholar
• HealthTTri-Hospital and Toronto Public Health: Health Equity Data Collection Research Project ReportToronto Public Health, St Michael’s Hospital, Centre for Addiction and Mental HealthMount Sinai Hospital2013
   Google Scholar
• ReynoldsNRSunJNagarajaHNGiffordALWuAWChesneyMAOptimizing measurement of self-reported adherence with the ACTG Adherence Questionnaire: a cross-protocol analysisJ Acquir Immune Defic Syndr200746440240918077832
   PubMed Web of Science ®Google Scholar
• GendlerPECoviakCPMartinJTRevision of the osteoporosis knowledge test: reliability and validityWest J Nurs Res201537121623164324923463
   PubMed Web of Science ®Google Scholar
• ParkerSCiaccioMCookEValidation of a modified FRAX® tool for improving outpatient efficiency – part of the “Catch Before a Fall” initiativeArch Osteoporos201510125
   Web of Science ®Google Scholar
• HungAHamidiMRiazantsevaEValidation of a calcium assessment tool in postmenopausal Canadian womenMaturitas201169216817221450422
   PubMed Web of Science ®Google Scholar
• WeeksBKBeckBRThe BPAQ: a bone-specific physical activity assessment instrumentOsteoporos Int200819111567157718414964
   PubMed Web of Science ®Google Scholar
• de GruijlFRPavelSThe effects of a mid-winter 8-week course of sub-sunburn sunbed exposures on tanning, vitamin D status and coldsPhotochem Photobiol Sci201211121848185423104230
   PubMed Web of Science ®Google Scholar
• LagunovaZPorojnicuACAksnesLEffect of vitamin D supple-mentation and ultraviolet B exposure on serum 25-hydroxyvitamin D concentrations in healthy volunteers: a randomized, crossover clinical trialBr J Dermatol2013169243444023551243
   PubMed Web of Science ®Google Scholar
• TangprichaVTurnerASpinaCDecastroSChenTCHolickMFTanning is associated with optimal vitamin D status (serum 25-hydroxyvitamin D concentration) and higher bone mineral densityAm J Clin Nutr20048061645164915585781
   PubMed Web of Science ®Google Scholar
• ThiedenEJørgensenHLJørgensenNRPhilipsenPAWulfHCSunbed radiation provokes cutaneous vitamin D synthesis in humans – a randomized controlled trialPhotochem Photobiol20088461487149218513233
   PubMed Web of Science ®Google Scholar
• WeberBBachmannCCBraunRAbrahamAGSerraALHofbauerGFL25-Hydroxyvitamin-D3 serum modulation after use of sunbeds compliant with European Union standards: a randomized open observational controlled trialJ Am Acad Dermatol2017771485428416344
   PubMed Web of Science ®Google Scholar
• HoranMLKimKKGendlerPFromanRDPatelMDDevelopment and evaluation of the Osteoporosis Self-Efficacy ScaleRes Nurs Health19982153954039761137
   PubMed Web of Science ®Google Scholar
• WardleJSteptoeASocioeconomic differences in attitudes and beliefs about healthy lifestylesJ Epidemiol Community Health200357644044312775791
   PubMed Web of Science ®Google Scholar
• Health CanadaEating well with Canada’s food guide2011 Available from: http://www.hc-sc.gc.ca/fn-an/food-guide-aliment/index-eng.phpAccessed October 11, 2018
   Google Scholar
• VanlintSJRiedKEfficacy and tolerability of calcium, vitamin D and a plant-based omega-3 oil for osteopenia: a pilot RCTMaturitas2012711444822078660
   PubMed Web of Science ®Google Scholar
• BruyèreODeroisyRDardenneNA phase IV, two-armed, randomized, cross-over study comparing compliance with once-a-month administration of vitamin D3 to compliance with daily administration of a fixed-dose combination of vitamin D3 and calcium during two 6-month periodsOsteoporos Int201526122863286826100413
   PubMed Web of Science ®Google Scholar